Accumulating evidence has suggested that microRNA-449b-5p (miR-449b-5p) plays an important role in the development and progression of multiple
cancers. However, little is known about the role of miR-449b-5p in
breast cancer. In this study, we aimed to investigate the expression level, biological function and underlying mechanism of miR-449b-5p in
breast cancer. Our results showed that miR-449b-5p expression was frequently down-regulated in
breast cancer cell lines and tissues. The overexpression of miR-449b-5p significantly inhibited growth and invasion, and induced the cell cycle arrest of
breast cancer cells. In contrast, the inhibition of miR-449b-5p showed the opposite effect. Interestingly, bioinformatic analysis predicted that cell cycle-related and expression-elevated
protein in
tumor (CREPT), an important oncogene in
breast cancer, was a potential target gene of miR-449b-5p. The overexpression of miR-449b-5p decreased CREPT expression while miR-449b-5p inhibition promoted CREPT expression in
breast cancer cells. Restoration of CREPT expression in miR-449b-5p mimics transfected cells partially reversed the suppressive effect of miR-449b-5p on
breast cancer cell growth and invasion. Notably, our results showed that miR-449b-5p overexpression decreased the expression of β-
catenin and suppressed the activation of Wnt/β-
catenin/TCF-4 signaling via targeting CREPT. In addition, blocking Wnt/β-
catenin partially reversed the promotion effect of miR-449b-5p inhibition on
breast cancer cell growth and invasion. Overall, these results reveal a
tumor suppressive role of miR-449b-5p that restricts the growth and invasion of
breast cancer cells through targeting CREPT and inhibiting CREPT-mediated activation of Wnt/β-
catenin signaling. Our study suggests that the miR-449b-5p/CREPT/Wnt/β-
catenin axis may play an important role in the pathogenesis of
breast cancer and miR-449-5p may serve as a potential therapeutic target for
breast cancer.